MLN Product (Revised); Treatment (SBIRT) Services (PDF) to SBIRT Services
This revised product comprises Subregulatory Guidance for Screening, Brief Intervention, & Referral to Treatment (SBIRT) Services. Our MLN products explain national Medicare policy in an easy-to-understand format; and the underlying policy is already cleared and publically available. This revised MLN Product includes information that is available to the public and posted at SSA Section 1862(a)(1)(A), 42 CFR Section 410.20, 42 CFR Section 410.71, 42 CFR Section 410.73, 42 CFR Section 410.74, 42 CFR Section 410.75, 42 CFR Section 410.76, 42 CFR Section 410.77, Medicare Benefit Policy Manual, Chapter 15, Section 30, Medicare Benefit Policy Manual, Chapter 15, Section 80.2, Medicare Benefit Policy Manual, Chapter 15, Section 160, Medicare Benefit Policy Manual, Chapter 15, Section 170, Medicare Benefit Policy Manual, Chapter 15, Section 180, Medicare Benefit Policy Manual, Chapter 15, Section 190, Medicare Benefit Policy Manual, Chapter 15, Section 200, and Medicare Benefit Policy Manual, Chapter 15, Section 210. CMS policy or operation subject matter experts also reviewed/cleared this product. This revised Product contains text in red font which reflects changes to previous version dated March 2020. The previous version of this Product is currently posted on CMS website at Screening, Brief Intervention, & Referral to Treatment (SBIRT) Services.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: May 12, 2023
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.